Sbi Capital Securities

Mahantesh Sabarad, Deputy Vice President - Research at SBI Capital Securities likes Maruti Suzuki with a target of Rs 5100 and has a target of Rs 2800 for Hero Motocorp.

Prefer Power Grid: Mahantesh Sabarad

Mahantesh Sabarad, Deputy Vice President - Research at SBI Capital Securities is of the view that one may prefer Power Grid.

Like Jubilant Life Sciences, says Mahantesh Sabarad

Mahantesh Sabarad, Deputy Vice President - Research at SBI Capital Securities likes Jubilant Life Sciences.

HeidelbergCement favourite in cement space: SBI Cap

Mahantesh Sabarad, Deputy VP-Research at SBI Capital Securities is of the view that HeidelbergCement India is the favourite in the cement space.

Look at GlaxoSmithKline Consumer: Mahantesh Sabarad

Mahantesh Sabarad, Deputy VP - Research at SBI Capital Securities is of the view that one may look at GlaxoSmithKline Consumer Healthcare.

Prefer Allcargo Logistics, look at Dish TV: SBI Capital Sec

Mahantesh Sabarad, Deputy VP - Research at SBI Capital Securities is of the view that one may prefer Allcargo Logistics and feels that one may look at Dish TV.

Buy Infosys, says Mahantesh Sabarad

Mahantesh Sabarad, Deputy VP - Research at SBI Capital Securities is of the view that one can buy Infosys.

Tata Motors appears attractive, says Mahantesh Sabarad

Mahantesh Sabarad, Deputy VP - Research at SBI Capital Securities is of the view that Tata Motors appears attractive.

Hold HCL Technologies, target Rs 970: Dipesh Mehta

Dipesh Mehta, IT Analyst at SBI Capital Securities has a hold rating in HCL Technologies with a target of Rs 970.

Buy YES Bank, says Mahantesh Sabarad

Mahantesh Sabarad, Deputy VP-Research at SBI Capital Securities is of the view that one can buy YES Bank.

Look at Infosys: Mahantesh Sabarad

Mahantesh Sabarad, Deputy VP-Research at SBI Capital Securities is of the view that one may look at Infosys.

Buy Tata Motors, advises Mahantesh Sabarad

Mahantesh Sabarad, Deputy VP of Research at SBI Capital Securities is of the view that Tata Motors is worth buying into.

Buy Sun Pharmaceutical Industries: Mahantesh Sabarad

Mahantesh Sabarad, Deputy VP of Research at SBI Capital Securities recommends buying Sun Pharmaceutical Industries.

Prefer UltraTech Cement, Bank of Baroda: Mahantesh Sabarad

Mahantesh Sabarad - Deputy VP - Research at SBI Capital Securities is of the view that one may prefer UltraTech Cement and Bank of Baroda.

Buy Jubilant Life Sciences , advises Mahantesh Sabarad

Mahantesh Sabarad - Deputy VP - Research at SBI Capital Securities recommends buying Jubilant Life Sciences.

Hold IndusInd Bank, says Mahantesh Sabarad

Mahantesh Sabarad, Deputy VP-Research at SBI Capital Securities recommends holding IndusInd Bank.

Buy Sun Pharma for long term: Mahantesh Sabarad

Mahantesh Sabarad, Deputy VP-Research at SBI Capital Securities recommends buying Sun Pharma for long term.

Look at Voltas, Blue Star: Mahantesh Sabarad

Mahantesh Sabarad, Deputy VP - Research at SBI Capital Securities is of the view that one may look at Voltas and Blue Star.

Mahantesh Sabarad positive on YES Bank

Mahantesh Sabarad, Deputy VP - Research at SBI Capital Securities has a positive view on YES Bank.

Firstsource Solutions may touch Rs 55: Mahantesh Sabarad

According to Mahantesh Sabarad, Deputy Head of Research at SBI Capital Securities, Firstsource Solutions may touch Rs 55.

Adani Ports may test Rs 327: Mahantesh Sabarad

Mahantesh Sabarad, Deputy Head of Research at SBI Capital Securities is of the view that Adani Ports may head higher and test Rs 327.

Pick Allcargo Logistics, target Rs 361: Mahantesh Sabarad

Mahantesh Sabarad, Deputy Head of Research at SBI Capital Securities recommends picking Allcargo Global as the stock may test Rs 361.

Bajaj Finance may test Rs 3220: Mahantesh Sabarad

Mahantesh Sabarad, Deputy Head of Research at SBI Capital Securities is of the view that Bajaj Finance may test Rs 3220.

Hold Maruti Suzuki India, says Mahantesh Sabarad

Mahantesh Sabarad, Deputy Head of Research at SBI Capital Securities recommends holding Maruti Suzuki India.

Expect Insecticides to hit Rs 898: Mahantesh Sabarad

Mahantesh Sabarad, Deputy Head of Research at SBI Capital Securities is of the view that Insecticides India may hit Rs 898.